Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Interventional, Single-Center, Single-Arm Clinical Study to Evaluate the Clinical Improvement of Neonatal Hyperseborrhea ("Cradle Cap"), Including Potential Cutaneous Manifestations Associated With Mild-to-Moderate Seborrheic Dermatitis, and the Cutaneous Tolerability of the Cosmetic Product TRIDERM D.S. Crema Normalizzante.

NCT07860788 is registered in ClinicalTrials.gov with ICIM International S.r.l. as lead sponsor.

NCT NCT07860788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07860788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Interventional, Single-Center, Single-Arm Clinical Study to Evaluate the Clinical Improvement of Neonatal Hyperseborrhea ("Cradle Cap"), Including Potential Cutaneous Manifestations Associated With Mild-to-Moderate Seborrheic Dermatitis, and the Cutaneous Tolerability of the Cosmetic Product TRIDERM D.S. Crema Normalizzante.
Lead sponsor
ICIM International S.r.l.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
February 28, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cradle cap, seborrheic dermatitis